Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling
    7.
    发明授权
    Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling 有权
    化合物累积在炎症部位,含有标记状态的化合物的诊断剂及其前体化合物进行标记

    公开(公告)号:US09044520B2

    公开(公告)日:2015-06-02

    申请号:US13434722

    申请日:2012-03-29

    IPC分类号: A61K51/00 A61M36/14 A61K51/08

    CPC分类号: A61K51/088 G01N2800/042

    摘要: Embodiments of the invention provide a compound accumulating in an inflammatory site, a diagnostic agent containing the compound in labeled state and its precursor compound for labeling. Such a compound accumulating in inflammatory site may be represented by the following formula (1): Z—Y-Leu-Phe-(X)n-DLys(-(DLys)m-HalB)-(DLys)k-NH2  (1) wherein in the formula (1), Z represents a protective group for an amino group; Y represents Met or Nle; X represents a spacer consisting of one or more of amino acid and/or synthetic organic compounds; n represents 1 or 0; m represents 1 or 0; k represents 1 or 0; and HalB represents a substituted benzoic acid having a radioactive halogen in an aromatic ring.

    摘要翻译: 本发明的实施方案提供了一种在炎症部位中积聚的化合物,含有标记状态的化合物的诊断剂及其用于标记的前体化合物。 Z-Y-Leu-Phe-(X)n-DLys( - (DLys)m-HalB) - (DLys)k-NH 2(1)的化合物可以由下述式(1)表示: )其中在式(1)中,Z表示氨基的保护基; Y表示Met或Nle; X表示由一种或多种氨基酸和/或合成有机化合物组成的间隔物; n表示1或0; m表示1或0; k表示1或0; HalB表示在芳香环中具有放射性卤素的取代苯甲酸。

    SWITCHING FLUORESCENT NANOPARTICLE PROBE AND FLUORESCENT PARTICLE IMAGING METHOD USING SAME
    8.
    发明申请
    SWITCHING FLUORESCENT NANOPARTICLE PROBE AND FLUORESCENT PARTICLE IMAGING METHOD USING SAME 有权
    切换荧光纳米粒子探针和使用其的荧光颗粒成像方法

    公开(公告)号:US20130149252A1

    公开(公告)日:2013-06-13

    申请号:US13818392

    申请日:2011-08-08

    IPC分类号: A61K49/00

    摘要: The present invention provides a novel fluorescent nanoparticle imaging probe having a switching function (a function to quench a fluorescent dye during nanoparticle preparation, and emit fluorescence during imaging). A switching fluorescent nanoparticle probe comprising: a molecular assembly composed of an amphiphilic block polymer having a hydrophilic block chain and a hydrophobic block chain; and a fluorescent dye encapsulated in the molecular assembly, wherein (a) the hydrophilic block chain comprises, as an essential hydrophilic structural unit, a unit selected from a sarcosine unit and an alkylene oxide unit, (b) the hydrophobic block chain comprises, as an essential hydrophobic structural unit, a unit selected from the group consisting of an amino acid unit and a hydroxylic acid unit, and (c) the fluorescent dye is a cyanine compound represented by the formula (I): and two or more molecules of the fluorescent dye are encapsulated in the single molecular assembly.

    摘要翻译: 本发明提供了具有开关功能(在纳米颗粒制备期间淬灭荧光染料并在成像期间发射荧光的功能)的新型荧光纳米颗粒成像探针。 一种开关荧光纳米颗粒探针,包括:由具有亲水嵌段链和疏水性嵌段链的两亲嵌段聚合物组成的分子组合; 以及包封在分子组合中的荧光染料,其中(a)所述亲水性嵌段链包含作为必需亲水性结构单元的选自肌氨酸单元和烯化氧单元的单元,(b)所述疏水性嵌段链包含: 必需的疏水结构单元,选自氨基酸单元和羟基酸单元的单元,和(c)荧光染料是由式(I)表示的花青化合物:和 荧光染料被封装在单分子组装中。

    COMPOUND ACCUMULATING IN INFLAMMATORY SITE, DIAGNOSTIC AGENT CONTAINING THE COMPOUND IN LABELED STATE AND ITS PRECURSOR COMPOUND FOR LABELING
    10.
    发明申请
    COMPOUND ACCUMULATING IN INFLAMMATORY SITE, DIAGNOSTIC AGENT CONTAINING THE COMPOUND IN LABELED STATE AND ITS PRECURSOR COMPOUND FOR LABELING 有权
    包含化合物在标签状态的诊断试剂盒及其前体化合物标签中的化合物累积

    公开(公告)号:US20120253010A1

    公开(公告)日:2012-10-04

    申请号:US13434722

    申请日:2012-03-29

    IPC分类号: C07K7/06

    CPC分类号: A61K51/088 G01N2800/042

    摘要: Embodiments of the invention provide a compound accumulating in an inflammatory site, a diagnostic agent containing the compound in labeled state and its precursor compound for labeling. Such a compound accumulating in inflammatory site may be represented by the following formula (1): Z—Y-Leu-Phe-(X)n-DLys(-(DLys)m-HalB)-(DLys)k-NH2  (1) wherein in the formula (1), Z represents a protective group for an amino group; Y represents Met or Nle; X represents a spacer consisting of one or more of amino acid and/or synthetic organic compounds; n represents 1 or 0; m represents 1 or 0; k represents 1 or 0; and HalB represents a substituted benzoic acid having a radioactive halogen in an aromatic ring.

    摘要翻译: 本发明的实施方案提供了一种在炎症部位中积聚的化合物,含有标记状态的化合物的诊断剂及其用于标记的前体化合物。 Z-Y-Leu-Phe-(X)n-DLys( - (DLys)m-HalB) - (DLys)k-NH 2(1)的化合物可以由下述式(1)表示: )其中在式(1)中,Z表示氨基的保护基; Y表示Met或Nle; X表示由一种或多种氨基酸和/或合成有机化合物组成的间隔物; n表示1或0; m表示1或0; k表示1或0; HalB表示在芳香环中具有放射性卤素的取代苯甲酸。